LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICLTM) for myopia, astigmatism and presbyopia, is proud to announce the expansion and new location of the STAAR Surgical Experience Center.

加利福尼亚州森林湖——（商业新闻短讯）——STAAR Surgical Company（纳斯达克股票代码：STAA）是用于近视、散光和老视的EVO系列可植入Collamer®镜片（EVO ICLTM）的领先开发商、制造商和销售商，非常自豪地宣布STAAR Surgical Experience Center的扩建和新位置。

Located at STAAR’s headquarters in Lake Forest, California, near John Wayne Airport (SNA), the center serves as a dynamic hub for comprehensive, hands-on training and education in lens-based vision correction..

该中心位于加利福尼亚州森林湖的斯塔尔总部，靠近约翰·韦恩机场（SNA），是一个动态的中心，为基于镜头的视力矫正提供全面的实践培训和教育。。

The new Experience Center is a critical addition to customer training, education and support as the demand for EVO ICL continues to surge among surgeons and refractive practices, driven by the escalating global myopia epidemic. The prevalence of myopia in Americans is 42%3, having doubled over the past three decades3, while laser refractive procedure volume is declining.

由于全球近视流行不断升级，外科医生和屈光手术对EVO ICL的需求持续激增，新的体验中心是客户培训、教育和支持的重要补充。美国人近视的患病率为42%[3]，在过去的三十年中翻了一番[3]，而激光屈光手术的数量正在下降。

EVO ICL is rapidly disrupting the refractive market. STAAR Surgical is on track to sell more ICLs between 2024 and 2026 than in the first 25 years of ICL sales combined, reflecting the transformative impact of this technology following FDA approval and market launch..

EVO ICL正在迅速扰乱屈光市场。STAAR Surgical有望在2024年至2026年间销售更多的ICL，超过ICL销售的前25年总和，这反映了该技术在FDA批准和市场推出后的变革性影响。。

“We are thrilled to open our expanded Experience Center, offering cutting-edge resources and training for ophthalmic professionals,” said Tom Frinzi, President and CEO of STAAR Surgical. “The center reflects our commitment to supporting the growing demand for EVO ICL and advancing its global adoption.”.

STAAR Surgical总裁兼首席执行官汤姆·弗林齐（TomFrinzi）表示：“我们很高兴能够开设扩展的体验中心，为眼科专业人员提供尖端资源和培训。”。“该中心反映了我们对支持EVO ICL不断增长的需求并推动其全球采用的承诺。”。

The Experience Center elevates the standard of care by equipping healthcare practitioners—MDs, ODs, and support staff—with the tools and knowledge to optimize EVO ICL patient outcomes. It offers advanced visualization and communication technology for both in-person and virtual training. Highlights include:.

体验中心通过为医疗保健从业人员MDs、ODs和支持人员提供优化EVO ICL患者结局的工具和知识，提高了护理标准。它为面对面和虚拟培训提供了先进的可视化和通信技术。亮点包括：。

Immersive wet lab training stations for up to 24 practitioners, with seating for 59 in lectures

沉浸式湿实验室培训站，最多可供24名从业者使用，讲座中可容纳59人

Stella™, STAAR’s latest innovation in ordering, streamlines and enhances the EVO ICL planning and ordering process

Stella™是STAAR在订购方面的最新创新，它简化并增强了EVO ICL计划和订购流程

Advanced diagnostic technology demonstrations, including the OCULUS Pentacam® AXL Wave, IOLMaster 700 and CIRRUS 6000

先进的诊断技术演示，包括OCULUS Pentacam®AXL Wave、IOLMaster 700和CIRRUS 6000

120-inch 4K video array for video conferencing and streaming of remote live surgery to enhance training

120英寸4K视频阵列，用于视频会议和远程实时手术流媒体，以增强训练

The center will officially open on September 26 with a grand opening event attended by local ophthalmic surgeons and staff, EVO patients, and STAAR management and clinical staff, including Tom Frinzi, President and CEO of STAAR Surgical, Warren Foust, COO of STAAR Surgical, and Dr. Scott Barnes, STAAR’s Chief Medical Officer..

该中心将于9月26日正式开业，当地眼科外科医生和工作人员、EVO患者、STAAR管理层和临床工作人员将出席盛大的开业活动，其中包括STAAR外科总裁兼首席执行官汤姆·弗林齐、STAAR外科首席运营官沃伦·福斯特和STAAR首席医疗官斯科特·巴恩斯博士。。

STAAR Surgical offers a comprehensive range of professional education programs to support ophthalmic professionals at every stage with EVO ICL. From onboarding to advanced practice, STAAR provides certification through digital training, wet labs, peer mentorship, and proctorship. STAAR also hosts live webinars, an annual surgeon summit and offers on-demand resources via STAAR University for ongoing support tailored to both MDs and ODs..

STAAR Surgical提供全面的专业教育计划，以支持EVO ICL在每个阶段的眼科专业人员。从入职到高级实践，STAAR通过数字培训、湿实验室、同伴辅导和监考提供认证。。。

For more information or to schedule a visit, please contact Jaimie Morgan, STAAR Surgical, Senior Director of Strategic and Professional Education, at (714) 353-6942.

欲了解更多信息或安排访问，请联系战略和专业教育高级总监Jaimie Morgan，STAAR Surgical，电话（714）353-6942。

For more information about EVO Implantable Collamer® Lenses, visit https://evoicl.com. Connect with us on social media at: Facebook, Instagram, and LinkedIn.

有关EVO植入式Collamer®镜片的更多信息，请访问https://evoicl.com.通过社交媒体与我们联系：Facebook、Instagram和LinkedIn。

1Bullimore MA, Brennan NA. The underestimated role of myopia in uncorrectable visual impairment in the United States. Scientific Reports. 2023 Sep 13.

1Bullimore MA，Brennan NA。近视在美国无法矫正的视力障碍中被低估的作用。科学报告。2023年9月13日。

2STAAR Surgical data on file.

2STAAR手术数据存档。

3Banashefski B, Rhee MK, Lema GMC. High Myopia Prevalence across Racial Groups in the United States: A Systematic Scoping Review. J Clin Med. 2023 Apr 21;12(8):3045.

3巴纳舍夫斯基B，Rhee MK，Lema GMC。美国种族群体的高度近视患病率：系统范围界定综述。J临床医学杂志2023年4月21日；12（8）：3045。

About STAAR Surgical

关于STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision.

。这些镜片旨在为患者提供视觉自由，减少或消除对眼镜或隐形眼镜的依赖。所有这些镜片都是可折叠的，这使得外科医生可以通过一个小切口将它们插入。

STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 3,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA, and Nidau, Switzerland.

用于屈光手术的STAAR晶状体被称为植入式Collamer®晶状体或“ICL”，其中包括EVO ICL™产品线。迄今为止，已售出300多万个ICL，STAAR在75多个国家销售这些镜片。。

For more information, please visit the Company’s website at www.staar.com..

欲了解更多信息，请访问公司网站www.staar.com。。

Important Safety Information

重要安全信息

The EVO Visian ICL lens is intended to correct/reduce nearsightedness between -3.0 D up to -20.0 D and treat astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before.

EVO Visian ICL镜片旨在矫正/减少-3.0 D至-20.0 D的近视，并治疗1.0 D至4.0 D的散光。如果您的近视在这些范围内，EVO Visian ICL手术可能会改善您的远视力，而无需眼镜或隐形眼镜。因为EVO Visian ICL可以校正远视，所以它并不能消除对阅读眼镜的需求，即使您以前从未戴过，您也可能会在某些时候需要它们。

Since the implantation of the EVO Visian ICL is a surgical procedure, before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.

由于植入EVO Visian ICL是一种外科手术，因此在考虑EVO Visian ICL手术之前，您应该进行全面的眼部检查，并与您的眼科护理专业人员讨论EVO Visian ICL手术，特别是潜在的益处，风险和并发症。你应该讨论手术后愈合所需的时间。

Complications, although rare, may include the need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts. You should NOT have EVO Visian ICL surgery if your doctor determines that 1) the shape of your eye is not appropriate, 2) you do not meet the minimum endothelial cell density for your age at the time of implantation, 3) you have moderate to severe glaucoma, 4) your vision is not stable; or 5) if you are pregnant or nursing..

并发症虽然很少见，但可能包括需要额外的外科手术，炎症，角膜后表面细胞的丢失，眼压升高和白内障。如果您的医生确定1）您的眼睛形状不合适，2）您在植入时不符合您年龄的最低内皮细胞密度，3）您患有中度至重度青光眼，4）您的视力不稳定；或5）如果你怀孕或哺乳。。

For additional information with potential benefits, risks and complications please visit DiscoverICL.com.

有关潜在益处、风险和并发症的更多信息，请访问DiscoverICL.com。